We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $26.4B
1-Year Est. Return 44.85%
This Fund
S&P 500
This Quarter Est. Return
+2.52%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
AUM
$7.16B
AUM Growth
+$666M
Cap. Flow
+$831M
Cap. Flow %
11.61%
Top 10 Hldgs %
17.05%
Holding
983
New
189
Increased
207
Reduced
145
Closed
240

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$73.2M
2
PANW icon
Palo Alto Networks
PANW
+$59.8M
3
ALKS icon
Alkermes
ALKS
+$55.3M
4
ACN icon
Accenture
ACN
+$53.8M
5
JNJ icon
Johnson & Johnson
JNJ
+$53M

Sector Composition

Rank Sector Weight
1 Healthcare 36.05%
2 Technology 29.2%
3 Financials 8.76%
4 Industrials 7.7%
5 Communication Services 4.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TDY icon
51
Teledyne Technologies
TDY
$31.1B
$33.1M 0.46%
98,200
+47,425
+93% +$18.1M
SWCH
52
DELISTED
Switch, Inc. Class A Common Stock
SWCH
$32.2M 0.45%
955,000
+5,000
+0.5% +$169K
AVLR
53
DELISTED
Avalara, Inc.
AVLR
$32.1M 0.45%
349,283
-73,685
-17% -$6.6M
CARR icon
54
Carrier Global
CARR
$52.1B
$31.6M 0.44%
889,651
+356,295
+67% +$14M
ESMT
55
DELISTED
EngageSmart, Inc.
ESMT
$31.4M 0.44%
1,518,950
-180,964
-11% -$3.55M
SNX icon
56
TD Synnex
SNX
$20.3B
$31.3M 0.44%
385,868
+312,467
+426% +$29.9M
A icon
57
Agilent Technologies
A
$39.5B
$30.6M 0.43%
251,503
+21,800
+9% +$2.8M
AMN icon
58
AMN Healthcare
AMN
$1.28B
$30.6M 0.43%
+288,509
New +$31.6M
CRWD icon
59
CrowdStrike
CRWD
$206B
$29.3M 0.41%
+710,848
New +$32.5M
NOK icon
60
Nokia
NOK
$52.3B
$29.2M 0.41%
6,835,266
+4,798,123
+236% +$23.3M
RAPT
61
DELISTED
RAPT Therapeutics
RAPT
$29.1M 0.41%
151,061
+43,685
+41% +$8.26M
ZEN
62
DELISTED
ZENDESK INC
ZEN
$29.1M 0.41%
382,000
-74,000
-16% -$5.62M
DOV icon
63
Dover
DOV
$27.7B
$29M 0.41%
248,935
+12,424
+5% +$1.59M
DD icon
64
DuPont de Nemours
DD
$19.1B
$28.9M 0.4%
+456,793
New +$32.6M
FTNT icon
65
Fortinet
FTNT
$120B
$28.8M 0.4%
+585,738
New +$31.7M
AMLX icon
66
Amylyx Pharmaceuticals
AMLX
$2.24B
$28.7M 0.4%
1,020,384
+630,155
+161% +$15.7M
EVOP
67
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
$28.6M 0.4%
+859,505
New +$26.5M
ANAB icon
68
AnaptysBio
ANAB
$1.59B
$28.3M 0.4%
1,110,162
+189,524
+21% +$4.44M
FLS icon
69
Flowserve
FLS
$9.78B
$28.2M 0.39%
1,160,241
+686,389
+145% +$20.8M
TGNA
70
DELISTED
TEGNA Inc
TGNA
$27.6M 0.39%
1,337,000
+254,000
+23% +$5.38M
PAYC icon
71
Paycom
PAYC
$7.86B
$27.6M 0.39%
83,773
+21,638
+35% +$7.45M
EPAM icon
72
EPAM Systems
EPAM
$5.6B
$27.4M 0.38%
75,775
+72,882
+2,519% +$27.9M
PFE icon
73
Pfizer
PFE
$143B
$27.4M 0.38%
626,853
FLYW icon
74
Flywire
FLYW
$2.05B
$27.4M 0.38%
1,191,393
-54,856
-4% -$1.31M
ZTS icon
75
Zoetis
ZTS
$32.3B
$27.1M 0.38%
+182,669
New +$30.5M

Similar funds

Woodline Partners's Q3 2022 Portfolio in Review

As of Q3 2022, Woodline Partners held 983 positions worth $7.16B, up 10% from $6.49B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Woodline Partners deployed $831M of net new capital in Q3 2022, opening 189 new positions and adding to 207 existing holdings. Its largest new stake was Amazon: 683,398 shares worth $77.2M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, up from 35% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Eli Lilly, an estimated $73.2M trimmed.

  • Woodline Partners's largest Q3 2022 buy was Amazon: 683,398 shares worth $77.2M.
  • Woodline Partners added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2022, an estimated $146M increase.
  • Woodline Partners's biggest Q3 2022 reduction was Eli Lilly, cutting an estimated $73.2M.
  • Woodline Partners fully exited Palo Alto Networks in Q3 2022, selling an estimated $59.8M.
  • Woodline Partners's ten largest holdings make up 17% of its $7.16B portfolio in Q3 2022.
  • Woodline Partners opened 189 new positions and closed 240 in Q3 2022.
  • Woodline Partners's portfolio value rose 10% quarter-over-quarter to $7.16B.

Based on Woodline Partners's 13F filing for Q3 2022, filed 14 Nov 2022.